CLINICAL CASE

Long-term effects of multimodality laser therapy in patient with drusenoid pigment epithelial detachment

About authors

Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Nadezhda A. Mahno
Volokolamskoe shosse, 30, korp. 2, Moscow, 123182, Russia; moc.liamg@7onham.adzedan

About paper

Author contribution: Takhchidi KhP — study concept and design, manuscript editing; Takhchidi NKh — literature analysis; Kasmynina TA — laser therapy; Mahno NA — data acquisition and processing, manuscript writing.

Compliance with ethical standards: the patients submitted the informed consent to laser therapy and personal data processing.

Received: 2021-11-24 Accepted: 2021-12-16 Published online: 2021-12-29
|

Drusenoid pigment epithelial detachment is a condition characterized by separation of the retinal pigment epithelium from the underlying Bruch’s membrane due to formation of drusenoid deposits. The disorder represents the intermediate stage of the age-related macular degeneration, and is a risk factor for the age-related macular degeneration progression to late stage characterized by geographic atrophy, which results in the irreversible central vision loss. Management of patients with this disorder is in most cases limited to follow-up. The feasibility of using the multimodality low power mode laser therapy for treatment of drusenoid pigment epithelial detachment is reported. The results of laser photocoagulation of the retina demonstrate the morphological and functional recovery: retinal pigment epithelial detachment sealing, improvement of visual function, and restored retinal architecture.

Keywords: retina, micropulse laser, age-elated macular degeneration, drusenoid pigment epithelial detachment

КОММЕНТАРИИ (0)